Sprout Pharmaceuticals, Inc.
Records under this name other than the patents Sprout Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Back to Sprout Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,227,476 | Use of Flibanserin in the Treatment of Obesity Term ended Term ended Jul 31, 2026 · High confidence | Term ended | Term ended Jul 31, 2026 | High confidence |
| US 8,785,458 | Use of Flibanserin in the Treatment of Obesity Term ended Term ended Jul 31, 2026 · High confidence | Term ended | Term ended Jul 31, 2026 | High confidence |
| US 9,730,927 | Use of Flibanserin in the Treatment of Obesity Term ended Term ended Jul 31, 2026 · High confidence | Term ended | Term ended Jul 31, 2026 | High confidence |
| US 10,335,407 | Use of flibanserin in the treatment of obesity Term ended Ended no later than Jul 31, 2026 · From the USPTO record | Term ended | Ended no later than Jul 31, 2026 | From the USPTO record |
| US 10,874,668 | Use of Flibanserin in the treatment of obesity Term ended Ended no later than Jul 31, 2026 · From the USPTO record | Term ended | Ended no later than Jul 31, 2026 | From the USPTO record |
| US 10,596,170 | Treatment of vasomotor symptoms Lapsed on the fee record Ended Mar 24, 2024 · From the USPTO record | Lapsed on the fee record | Ended Mar 24, 2024 | From the USPTO record |
| US 8,227,471 | Treating Sexual Desire Disorders with Flibanserin Term ended Ended no later than Oct 22, 2023 · Medium confidence | Term ended | Ended no later than Oct 22, 2023 | Medium confidence |
| US 7,923,449 | Benzimidazolone Derivatives for the Treatment of Premenstrual and Other Female Sexual Disorders Lapsed on the fee record Ended Apr 12, 2023 · High confidence | Lapsed on the fee record | Ended Apr 12, 2023 | High confidence |
| US 7,183,410 | Stable Polymorph of Flibanserin Term ended Term ended Oct 30, 2022 · High confidence | Term ended | Term ended Oct 30, 2022 | High confidence |
| US 9,468,639 | Treating Sexual Desire Disorders with Flibanserin Term ended Term ended Oct 16, 2022 · Low confidence | Term ended | Term ended Oct 16, 2022 | Low confidence |